A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients

Jasmin N. Evers, Steven E. Schild, Barbara Segedin, Viorica Nagy, Mai Trong Khoa, Ngo Thuy Trang, Dirk Rades

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background/Aim: Elderly patients represent an important subgroup of patients with brain metastases. A survival score has been developed specifically for these patients. Patients and Methods: A total of 544 elderly patients (aged ≥65 years) receiving whole-brain radiotherapy alone were divided into a test (n=272) and a validation group (n=272). In the multivariate analysis of the test group, survival was significantly associated with gender, performance status, and number of organs involved by extracranial metastases. These factors were included in the score. Total scores representing the sum of the three factor scores were 3-13 points. Four prognostic groups were formed. Results: The 6-month survival rates were 2% for those with 3-6 points, 17% for those with 7-9 points, 56% for those with 10-12 points and 90% for those with 13 points in the test group (p<0.001), and 4%, 21%, 50% and 86%, respectively, in the validation group (p<0.001). Conclusion: This score is reproducible and helps estimate the survival prognosis of elderly patients with brain metastasis.

Original languageEnglish (US)
Pages (from-to)2455-2458
Number of pages4
JournalAnticancer Research
Volume34
Issue number5
StatePublished - May 1 2014

Fingerprint

Radiotherapy
Neoplasm Metastasis
Survival
Brain
Multivariate Analysis
Survival Rate

Keywords

  • Brain metastasis
  • Elderly patients
  • Prognostic factors
  • Score
  • Survival
  • Whole-brain radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Evers, J. N., Schild, S. E., Segedin, B., Nagy, V., Khoa, M. T., Trang, N. T., & Rades, D. (2014). A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. Anticancer Research, 34(5), 2455-2458.

A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. / Evers, Jasmin N.; Schild, Steven E.; Segedin, Barbara; Nagy, Viorica; Khoa, Mai Trong; Trang, Ngo Thuy; Rades, Dirk.

In: Anticancer Research, Vol. 34, No. 5, 01.05.2014, p. 2455-2458.

Research output: Contribution to journalArticle

Evers, JN, Schild, SE, Segedin, B, Nagy, V, Khoa, MT, Trang, NT & Rades, D 2014, 'A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients', Anticancer Research, vol. 34, no. 5, pp. 2455-2458.
Evers JN, Schild SE, Segedin B, Nagy V, Khoa MT, Trang NT et al. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. Anticancer Research. 2014 May 1;34(5):2455-2458.
Evers, Jasmin N. ; Schild, Steven E. ; Segedin, Barbara ; Nagy, Viorica ; Khoa, Mai Trong ; Trang, Ngo Thuy ; Rades, Dirk. / A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients. In: Anticancer Research. 2014 ; Vol. 34, No. 5. pp. 2455-2458.
@article{f7afc0d6fb904680985907152fe99fb6,
title = "A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients",
abstract = "Background/Aim: Elderly patients represent an important subgroup of patients with brain metastases. A survival score has been developed specifically for these patients. Patients and Methods: A total of 544 elderly patients (aged ≥65 years) receiving whole-brain radiotherapy alone were divided into a test (n=272) and a validation group (n=272). In the multivariate analysis of the test group, survival was significantly associated with gender, performance status, and number of organs involved by extracranial metastases. These factors were included in the score. Total scores representing the sum of the three factor scores were 3-13 points. Four prognostic groups were formed. Results: The 6-month survival rates were 2{\%} for those with 3-6 points, 17{\%} for those with 7-9 points, 56{\%} for those with 10-12 points and 90{\%} for those with 13 points in the test group (p<0.001), and 4{\%}, 21{\%}, 50{\%} and 86{\%}, respectively, in the validation group (p<0.001). Conclusion: This score is reproducible and helps estimate the survival prognosis of elderly patients with brain metastasis.",
keywords = "Brain metastasis, Elderly patients, Prognostic factors, Score, Survival, Whole-brain radiotherapy",
author = "Evers, {Jasmin N.} and Schild, {Steven E.} and Barbara Segedin and Viorica Nagy and Khoa, {Mai Trong} and Trang, {Ngo Thuy} and Dirk Rades",
year = "2014",
month = "5",
day = "1",
language = "English (US)",
volume = "34",
pages = "2455--2458",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients

AU - Evers, Jasmin N.

AU - Schild, Steven E.

AU - Segedin, Barbara

AU - Nagy, Viorica

AU - Khoa, Mai Trong

AU - Trang, Ngo Thuy

AU - Rades, Dirk

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Background/Aim: Elderly patients represent an important subgroup of patients with brain metastases. A survival score has been developed specifically for these patients. Patients and Methods: A total of 544 elderly patients (aged ≥65 years) receiving whole-brain radiotherapy alone were divided into a test (n=272) and a validation group (n=272). In the multivariate analysis of the test group, survival was significantly associated with gender, performance status, and number of organs involved by extracranial metastases. These factors were included in the score. Total scores representing the sum of the three factor scores were 3-13 points. Four prognostic groups were formed. Results: The 6-month survival rates were 2% for those with 3-6 points, 17% for those with 7-9 points, 56% for those with 10-12 points and 90% for those with 13 points in the test group (p<0.001), and 4%, 21%, 50% and 86%, respectively, in the validation group (p<0.001). Conclusion: This score is reproducible and helps estimate the survival prognosis of elderly patients with brain metastasis.

AB - Background/Aim: Elderly patients represent an important subgroup of patients with brain metastases. A survival score has been developed specifically for these patients. Patients and Methods: A total of 544 elderly patients (aged ≥65 years) receiving whole-brain radiotherapy alone were divided into a test (n=272) and a validation group (n=272). In the multivariate analysis of the test group, survival was significantly associated with gender, performance status, and number of organs involved by extracranial metastases. These factors were included in the score. Total scores representing the sum of the three factor scores were 3-13 points. Four prognostic groups were formed. Results: The 6-month survival rates were 2% for those with 3-6 points, 17% for those with 7-9 points, 56% for those with 10-12 points and 90% for those with 13 points in the test group (p<0.001), and 4%, 21%, 50% and 86%, respectively, in the validation group (p<0.001). Conclusion: This score is reproducible and helps estimate the survival prognosis of elderly patients with brain metastasis.

KW - Brain metastasis

KW - Elderly patients

KW - Prognostic factors

KW - Score

KW - Survival

KW - Whole-brain radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84902994915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902994915&partnerID=8YFLogxK

M3 - Article

C2 - 24778060

AN - SCOPUS:84902994915

VL - 34

SP - 2455

EP - 2458

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -